3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
17
Melanoma
3
Glioma
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Multiple Endocrine Neoplasia Type 1
2
Diffuse Intrinsic Pontine Glioma
2
Thymus Neoplasms
1
Teratoma
1
Solid Tumors Harboring a BRAF V600 Mutation
1
Rhabdoid Tumor
1
Osteitis Deformans
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms by Site
1
Mesothelioma
1
Medulloblastoma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Glioblastoma
1
Familial ependymoma
1
Fallopian Tube Neoplasms
1
Estrogen Receptor and/or Progesterone Receptor Positive
1
Cystadenocarcinoma, Serous
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
75
Cetuximab
63
Radiotherapy
38
pembrolizumab
29
Radiotherapy, Intensity-Modulated
28
Carboplatin
25
Fluorouracil
24
Docetaxel
24
Paclitaxel
19
Erlotinib Hydrochloride
13
Nivolumab
12
Radiation
10
Pemetrexed
10
durvalumab
8
Gemcitabine
8
Drug Therapy
8
Bevacizumab
7
zalutumumab
6
Surgical Procedures, Operative
6
Panitumumab
6
Lapatinib
6
Everolimus
6
Albumin-Bound Paclitaxel
6
130-nm albumin-bound paclitaxel
6
epacadostat
5
Standard of Care
5
Oxaliplatin
5
Gefitinib
5
Afatinib
5
Radiosurgery
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Head and Neck Neoplasms
×
ribociclib
×
Clear all
No trials found.